Sharps Technology, Inc. (NASDAQ: STSS) recently announced that the Company will be commercializing cutting-edge prefillable syringe system products to provide new solutions to customers in the ...

Every year, 9 million people self-inject with syringes for medical conditions, producing 3 billion used syringes–and that doesn’t include the needles used for illegal drugs. Instead of sending the ...

Sharps Technology Inc. (NASDAQ: STSS) is pushing into the copolymer prefillable syringe market thanks to a deal with Nephron Pharmaceuticals Corp., a leader in contract manufacturing of generic ...

Signed PO secures first 12 months of syringe product orders against Sharps and Nephron’s five-year, $200 million Syringe Sales Agreement. Current Asset Purchase Agreement closing timeline is on track ...

Medical device company Sharps Technology Inc. (NASDAQ: STSS) is taking stock as it approaches one year since its initial public offering (IPO). Since its IPO, the company has taken major strides in ...

Shares of Sharps Technology Inc (NASDAQ:STSS) are trading higher on Friday, with a heavy session volume of 15.17 million. On Wednesday, the medical device and pharmaceutical packaging company received ...

Sharps CEO issues letter to shareholders with details about the InjectEZ acquisition, establishing Sharps position in the prefillable syringe (PFS) industry in the U.S. Signed Syringe Sales Agreement ...

The Woodford County Health Department has launched a new Residential Sharps Disposal Program to allow residents to safely ...

Dynarex has debuted four new products geared toward safety. The SecureSafe™ Safety Syringes have an enhanced safety mechanism and include insulin safety syringes and allergy safety syringe trays. The ...

On the last Wednesday of every month, in the back corner of Falling Sky Pour House and Delicatessen in Eugene, members of Trans*Ponder — an education and advocacy nonprofit in Eugene that serves trans ...